Massachusetts Eye and Ear and Joslin Diabetes Center/Beetham Eye Institute (BEI) have formed a clinical alliance to deliver the highest-quality care to eye patients, especially those with or at risk for diabetic-related eye complications.
This collaboration provides a full array of general and subspecialty eye care, backed by advanced diagnostic and ancillary services and addressing the most complex vision and eye-related problems. From annual vision screening to diabetic eye care, cataract and refractive surgery, treatment of complicated glaucoma and cornea disease, macular and other retinal degenerations, cosmetic and ophthalmic plastic surgery, and vision rehabilitation, our physicians and staff provide world-class care to our patients.
About the Collaboration
This new collaboration brings together Boston's two most advanced clinical eye departments, Joslin's BEI and Mass. Eye and Ear's Department of Ophthalmology. The alliance will allow providers to offer patients coordinated, efficient and effective care.
BEI has long been a leader in both clinical care and research for patients with or at-risk of developing diabetes-related eye disease. The Institute is also a world leader in the design and development of clinical trials in diabetic retinopathy, and is involved in nearly every major clinical trial involving the treatment and prevention of diabetic retinopathy and macular edema in the United States.
The collaboration operates under the direction of medical director Lloyd Paul Aiello, MD, PhD. Dr. Aiello is a vice-chair in the Harvard Department of Ophthalmology, as well as an accomplished clinician-scientist and a leader in the Harvard Medical School angiogenesis research group. This group first identified vascular endothelial growth factor (VEGF) as a key regulator of abnormal new blood vessels in eye disease. Dr. Aiello is also chairperson of the Diabetic Retinopathy Clinical Research Network and he currently oversees Mass. Eye and Ear’s ophthalmology service at Brigham and Women’s Hospital.